Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy (2015)
- Authors:
- USP affiliated authors: BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM ; SILVA, CLOVIS ARTUR ALMEIDA DA - FM
- Unidade: FM
- DOI: 10.1016/j.vaccine.2014.12.030
- Subjects: ARTRITE REUMATOIDE (TERAPIA); VACINAS; POLISSACARÍDEOS BACTERIANOS; NECROSE
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
AIKAWA, Nadia E. et al. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy. Vaccine, v. 33, p. 604-609, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2014.12.030. Acesso em: 13 jun. 2024. -
APA
Aikawa, N. E., França, I. L. A., Ribeiro, A. C., Sallum, A. M. E., Bonfá, E., & Silva, C. A. (2015). Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy. Vaccine, 33, 604-609. doi:10.1016/j.vaccine.2014.12.030 -
NLM
Aikawa NE, França ILA, Ribeiro AC, Sallum AME, Bonfá E, Silva CA. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy [Internet]. Vaccine. 2015 ; 33 604-609.[citado 2024 jun. 13 ] Available from: https://doi.org/10.1016/j.vaccine.2014.12.030 -
Vancouver
Aikawa NE, França ILA, Ribeiro AC, Sallum AME, Bonfá E, Silva CA. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy [Internet]. Vaccine. 2015 ; 33 604-609.[citado 2024 jun. 13 ] Available from: https://doi.org/10.1016/j.vaccine.2014.12.030 - Doença periodontal em doenças reumáticas pediátricas
- Abatacept Related Infections: No Association with Gammaglobulin Reduction
- Lupus nephritis-related issues during COVID-19 pandemic quarantine
- Initial Benchmarking of the Quality of Medical Care in Childhood-Onset Systemic Lupus Erythematosus
- Pandemic non-adjuvanted influenza A H1N1 vaccine in a cohort of patients with systemic sclerosis
- Pediatric rheumatic disease patients: time to extend the age limit of adolescence?
- Behçet's discase activity: an important factor for immunogenicity of unadjuvanted influenza A/H1N1 vaccine
- Human Papilloma Virus and Chlamydia Trachomatis Infections in Rheumatoid Arthitis Under Anti-TNF Therapy
- Consenso da Sociedade Brasileira de Reumatologia para o diagnóstico, manejo e tratamento da nefrite lúpica
- Human papillomavirus and chlamydia trachomatis infections in rheumatoid arthritis under anti-TNF therapy: an observational study
Informações sobre o DOI: 10.1016/j.vaccine.2014.12.030 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
